Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
[Psychiatry]
Alexey Alexandrovich Krasnov; Andrey Georgievich Sinenchenko; Svetlana Nikolaevnа Kozlova;
In order to analyze the structure and prognostic significance of comorbid somatic pathology, 122 in hospital patients with neurosis were examined. The comparison group included 159 mentally healthy persons. The prognostic significance of psychosomatic comorbidity was assessed using the M. Charlson index (CCI). A statistically significant increase in the prevalence of somatic pathology was revealed in patients with neurosis (63.9 %) in comparison with the control group (46.5 %). Calculation of the CCI index showed an increase of emergencies likelihood (mortality) in patients with psychosomatic comorbidity by an average of 13.6 %.
References:
1. Nurgazizova A. K. Proiskhozhdenie, razvitie i sovremennaya traktovka ponyatij «komorbidnost’ » i «polimorbidnost’». Kazanskij medicinskij zhurnal. – Kazan Medical Journal. 2014;95(2):292-296. (In Russ.). https://doi.org/10.17816/KMJ2084
2. Sarsenbaeva G. I., Tursynbekova A. E. Sovremennye podhody k ocenke komorbidnosti u pacientov. CardioSomatika. – CardioSomatics. 2019;10(1):19-23. (In Russ.). https://doi.org/10.26442/22217185.2018.4.180073
3. Sharabchiev Yu. T., Antipov V. V., Antipova S. I. Komorbidnost’ – aktual’naya nauchnaya i nauchno-prakticheskaya problema mediciny HKHI veka. Medicinskie novosti. – Medical news. 2014;(8):6-11. (In Russ.).
4. Ferrán C., Adolfo A., Matthew J. P., Brian H., Rafael T.-S. [et al.]. Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis. Plos One. 2018;13(1):e0189091. https://doi.org/10.1371/journal.pone.0189091
5. Tugwell P., Knottnerus J. A. Multimorbidity and Comorbidity are now separate MESH headings. J. Clin. Epidemiol. 2019;(105):VI-VIII. https://doi.org/10.1016/j.jclinepi.2018.11.019
6. Jose M., Valderas M. D., Barbara S., Bonnie S., Chris S., Martin R. Defining comorbidity: implications for understanding health and health services. Ann. Fam. Med. 2009;7(4):357-363. https://doi.org/10.1370/afm.983
7. Dieset I., Andreassen O. A., Haukvik U. K. Somatic Comorbidity in schizophrenia: some possible biological mechanisms across the life span. Schizophr. Bull. 2016;42(6):1316-1319. https://doi.org/10.1093/schbul/sbw028
8. Moni M. A., Liò P. Como R: a software for disease comorbidity risk assessment. J. Clin. Bioinforma. 2014;4-8. https://doi.org/10.1186/2043-9113-4-8
9. Belinda J. G., James E. H., Ronan A. L., Elton R. E., Peter A. C. Comparison of measures of comorbidity for predicting disability 12-months post-injury. BMC Health Serv. Res. 2013;13(1):30. https://doi.org/10.1186/1472-6963-13-30
10. Münevver K., Melahat A., Ethem K. Assessment of comorbidity and use of prescription and nonprescription drugs in patients above 65 years attending family medicine outpatient clinics. Gerontol. Geriat. Med. 2019;6;5:2333721419874274. https://doi.org/10.1177/2333721419874274
11. Stanislaw P. S., Sarathi K., Christian J., Carla F. J., Thomas J. P. [et al.]. Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioner’s perspective. J. Emerg. Trauma Shock. 2015;8(4):224-231. https://doi.org/10.4103/0974-2700.161658
12. Jorge B., Duncan A. E., Kirsty M. R., Brimicombe D. J., Rupert A. P. Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study. BMJ Open. 2017;7(3):e012546. https://doi.org/10.1136/bmjopen-2016-012546
13. Strel’nik S. N., Shishkovskaya T. I. Komorbidnost’ bipolyarnogo affektivnogo rasstrojstva i somaticheskoj patologii: struktura, klinicheskoe znachenie. Medicinskij vestnik Bashkortostana. – Medical Bulletin of Bashkortostan. 2018;(13)3:75. (In Russ.).
14. Dovzhenko T. V., Carenko D. M., Yudeeva T. Yu. Bipolyarnoe affektivnoe rasstrojstvo. Klinicheskie aspekty i komorbidnost’ s drugimi rasstrojstvami. Konsul’tativnaya psihologiya i psihoterapiya. – Counseling psychology and psychotherapy. 2020;28(1):166-179. (In Russ.). https://doi.org/10.17759/cpp.2020280110
15. Snoek F. The challenge of treating comorbid mental health problems in patients with a somatic illness. Lancet Psychiatry. 2018;5(6):465. https://doi.org/10.1016/S2215-0366(18)30130-5
16. Agnafors S., Norman Kjellström A., Torgerson J., Rusner M. Somatic comorbidity in children and adolescents with psychiatric disorders. Eur. Child. Adolesc. Psychiatry. 2019;28(11):1517-1525. https://doi.org/10.1007/s00787-019-01313-9
17. Tsygankov B. D., Boev I. V., Odarchenko S. S. Fundamentals of boundary gerontopsychiatry. Medical News of North Caucasus. 2017;12(2):127-130. https://doi.org/10.14300/mnnc.2017.12036
18. Pompei P., Ales K. L., Mac K. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis. 1987;40(5):373-383. https://doi.org/10.1016/0021-9681(87)90171-8
Keywords: borderline mental disorders, comorbidity, emergency conditions